Your search history is turned on.
Date: March 31, 2021 Jurisdictions: Alberta, British Columbia, Saskatchewan
Microsoft Word - LatticeBio-033121.htm Lattice Announces Strategic Advisory Board BELGRADE, Mont.--(BUSINESS WIRE)--March 31, 2021--Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (Lattice or the Company), an emerging leader in psilocybin research and cannabis company, today announced the formation of its Strategic Advisory Board, a group of respected busines...
Date: March 19, 2021 Jurisdictions: Alberta, British Columbia, Saskatchewan
Lattice Announces Strategic Cannabis Supply Agreement With Firehouse Lattice Announces Strategic Cannabis Supply Agreement With Firehouse Lattice now positioned in the largest cannabis markets in Montana Finished product will be co-branded under Lattice and Firehouse brands BELGRADE, Mont.--(BUSINESS WIRE)--March 19, 2021--Lattice Biologics Ltd. (TSX-V: ...
Date: March 15, 2021 Jurisdictions: Alberta, British Columbia, Saskatchewan
Microsoft Word - LatticeBio-031521.htm Lattice Biologics Reorganizes to Focus on Psychedelics and Cannabis Therapies BELGRADE, Mont.--(BUSINESS WIRE)--March 15, 2021--Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (Lattice Biologics or the Company) announced today that the Company will change its business strategy to focus on the fast growing psychedelics an...
Date: March 3, 2021 Jurisdictions: Alberta, British Columbia, Saskatchewan
Lattice Biologics Ltd. Announces Resignation of Director Lattice Biologics Ltd. Announces Resignation of Director BELGRADE, Mont.--(BUSINESS WIRE)--March 3, 2021--Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (Lattice Biologics or the Company) announces that Mr. Donald McInnes has resigned as a director of the Company, effective immediately, so that he...
Date: March 1, 2021 Jurisdictions: Alberta, British Columbia, Saskatchewan
Lattice Biologics Ltd. Reports First Quarter 2021 Highlights BELGRADE, Mont.--(BUSINESS WIRE)--March 1, 2021--Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (Lattice Biologics or the Company) announces financial results for Q1 2021. Highlights of Three Months Ended December 31, 2020 Sales and Product Offerings Gross profit margin was 48.1% for the three months ende...
Form 52-109F\/2 Certification of lnterim Filings Venture lssuer Basic Certificate l, Donna Medina, lnterim Chief Financial Officer of Latticel Biologics Ltd. (formerly Blackstone Ventures Inc.), certify the following: l-. Review: I have reviewed the interim financial report ancl interim MD&A (together, the "interim filings") of Lattice Biologics Ltd. {formerly Blackstone Venl...
Lattice Biologics Ltd. Managements Discussion and Analysis Fiscal 2021 First Quarter For the Three Months Ended December 31, 2020 (Expressed in U.S. dollars) 2 The following management discussion and analysis (MD&A) is a review of operations, current financial position and ...
Lattice Biologics Ltd. Unaudited Condensed Interim Consolidated Financial Statements Fiscal 2021 First Quarter For the Three Month Period Ended December 31, 2020 and 2019 (Expressed in U.S. dollars) 2 To the Shareholders of Lattice Biologics Ltd.: Under Nat...
Date: January 28, 2021 Jurisdictions: Alberta, British Columbia, Saskatchewan
Lattice Biologics Ltd. Reports Fourth Quarter and Year End 2020 Highlights !"#$%&'())*+,-.,,/- 0))12&324567#6869)) *:,;)<=0*>:?= :@0*A B%4'CDAE FGB02&&%3&HDIJK&2&HK2L4DI3L'IJ%4MN68682&O5D24D&O6868( ...